PTC THERAPEUTICS, INC. ($PTCT)
Boulding Mark Elliott โ EXEC. VP AND CLO
Shares
3,081
Price
$69.36
Total Value
$213,698.16
Nearby Earnings
Feb 19, 2026
EPS:Est: -0.21
Revenue:Est: $289.25M
Feb 26, 2026
EPS:Est: -0.21
Transaction Details
| Insider | Boulding Mark Elliott |
|---|---|
| Title | EXEC. VP AND CLO |
| Transaction Date | Feb 18, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Shares Sold | 3,081 |
| Price per Share | $69.36 |
| Total Value | $213,698.16 |
| Shares Owned After | 108,231 |
| Derivative | No |
| Accession Number | 0001578852-26-000008 |
| Document | View SEC Filing |